Literature DB >> 5441549

Mechanism of excessive purine biosynthesis in hypoxanthine-guanine phosphoribosyltransferase deficiency.

L B Sorensen.   

Abstract

Certain gouty subjects with excessive de novo purine synthesis are deficient in hypoxanthineguanine phosphoribosyltransferase (HG-PRTase [EC 2.4.2.8]). The mechanism of accelerated uric acid formation in these patients was explored by measuring the incorporation of glycine-(14)C into various urinary purine bases of normal and enzyme-deficient subjects during treatment with the xanthine oxidase inhibitor, allopurinol. In the presence of normal HG-PRTase activity, allopurinol reduced purine biosynthesis as demonstrated by diminished excretion of total urinary purine or by reduction of glycine-(14)C incorporation into hypoxanthine, xanthine, and uric acid to less than one-half of control values. A boy with the Lesch-Nyhan syndrome was resistant to this effect of allopurinol while a patient with 12.5% of normal enzyme activity had an equivocal response. Three patients with normal HG-PRTase activity had a mean molar ratio of hypoxanthine to xanthine in the urine of 0.28, whereas two subjects who were deficient in HG-PRTase had reversal of this ratio (1.01 and 1.04). The patterns of (14)C-labeling observed in HG-PRTase deficiency reflected the role of hypoxanthine as precursor of xanthine. The data indicate that excessive uric acid in HG-PRTase deficiency is derived from hypoxanthine which is insufficiently reutilized and, as a consequence thereof, catabolized inordinately to uric acid. The data provide evidence for cyclic interconversion of adenine and hypoxanthine derivatives. Cleavage of inosinic acid to hypoxanthine via inosine does not contribute significantly to the formation of uric acid in either normal man or in patients with HG-PRTase deficiency.HG-PRTase was not completely absent in red blood cells from a boy with the Lesch-Nyhan syndrome; with hypoxanthine as substrate, the activity in erythrocyte hemolysates was 0.64% of normal values.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5441549      PMCID: PMC535769          DOI: 10.1172/JCI106316

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  PSEUDOFEEDBACK INHIBITION OF PURINE SYNTHESIS BY 6-MERCAPTOPURINE RIBONUCLEOTIDE AND OTHER PURINE ANALOGUES.

Authors:  R J MCCOLLISTER; W R GILBERT; D M ASHTON; J B WYNGAARDEN
Journal:  J Biol Chem       Date:  1964-05       Impact factor: 5.157

2.  Augmentation of the incorporation of hypoxanthine into nucleic acids by the administration of an inhibitor of xanthine oxidase.

Authors:  R POMALES; S BIEBER; R FRIEDMAN; G H HITCHINGS
Journal:  Biochim Biophys Acta       Date:  1963-05-28

3.  Uric acid production in gout.

Authors:  J E SEEGMILLER; A I GRAYZEL; L LASTER; L LIDDLE
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

4.  Excretion of hypoxanthine and xanthine in a genetic disease of purine metabolism.

Authors:  L Sweetman; W L Nyhan
Journal:  Nature       Date:  1967-08-19       Impact factor: 49.962

5.  Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase.

Authors:  F M Rosenbloom; J F Henderson; I C Caldwell; W N Kelley; J E Seegmiller
Journal:  J Biol Chem       Date:  1968-03-25       Impact factor: 5.157

6.  An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  W N Kelley; F M Rosenbloom; J Miller; J E Seegmiller
Journal:  N Engl J Med       Date:  1968-02-08       Impact factor: 91.245

7.  Liver xanthine oxidase in gouty patients.

Authors:  A Carcassi; R Marcolongo; E Marinello; G Riario-Sforza; C Boggiano
Journal:  Arthritis Rheum       Date:  1969-02

8.  Suppression of the shunt pathway in primary gout by azathioprine.

Authors:  L B Sorensen
Journal:  Proc Natl Acad Sci U S A       Date:  1966-03       Impact factor: 11.205

9.  Study of the utilization and excretion of dietary purines in a xanthinuric man.

Authors:  J H Ayvazian; S Skupp
Journal:  J Clin Invest       Date:  1966-12       Impact factor: 14.808

10.  The effects of azathioprine (imuran) on purine synthesis in clinical disorders of purine metabolism.

Authors:  W N Kelley; F M Rosenbloom; J E Seegmiller
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

View more
  13 in total

1.  Metabolism of purines in cultured normal and HPRT-deficient human fibroblasts.

Authors:  K Itiaba; M Banfalvi; J C Crawhall
Journal:  Biochem Genet       Date:  1973-02       Impact factor: 1.890

2.  [The demonstration of hypoxanthine-guanine phosphoribosyl transferase enzyme protein in Lesch-Nyhan Syndrome].

Authors:  W P Kaiser; H Stemberger; M M Müller
Journal:  Klin Wochenschr       Date:  1973-01-15

Review 3.  Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants.

Authors:  Rosa J Torres; Juan G Puig; H A Jinnah
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

4.  Clinical and biochemical observations on three cases of hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  D N Bunn; I K Moss; A Nicholls; J T Scott; M L Snaith; M R Watson
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

Review 5.  Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.

Authors:  Rong Fu; Chung-Jen Chen; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-05-28       Impact factor: 4.797

6.  Purine metabolism in normal and thioguanine-resistant neuroblastoma.

Authors:  A W Wood; M A Becker; J D Minna; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

7.  Hypoxanthine-guanine phosphoribosyltransferase: characteristics of the mutant enzyme in erythrocytes from patients with the Lesch-Nyhan syndrome.

Authors:  W J Arnold; J C Meade; W N Kelley
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

8.  Dietary-induced variation of hypoxanthine-guanine phosphoribosyl transferase activity in patients with the Lesch-Nyhan syndrome.

Authors:  W J Arnold; W N Kelley
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

9.  Purification of IMP:pyrophosphate phosphoribosyltransferases, catalytically incompetent enzymes in Lesch-Nyhan disease.

Authors:  C S Rubin; J Dancis; L C Yip; R C Nowinski; M E Balis
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

10.  Purine synthesis de novo in cultured lymphoblast cells derived from patients with gout.

Authors:  R B Gordon; B T Emmerson
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.